Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DAJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,555
Award facts
- Contract value 100% obligated
- $25,554.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,554.83 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Kevzara 200 mg/1.14 ml pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by January 13, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor specializing in delivering prescription medications, medical devices, and healthcare commodities to federal agencies. The company's federal contract portfolio demonstrates extensive experience supplying specialty medications and brand-name drugs across multiple therapeutic domains to the Department of Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular award for Kevzara, an injectable immunosuppressant medication, aligns with the company's established role as a critical vendor in the federal medical procurement supply chain.
Quick answers
Who was awarded contract SPE2DR26F9DAJ?
SPE2DR26F9DAJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9DAJ worth?
The government has obligated $25,555 on SPE2DR26F9DAJ.
Is contract SPE2DR26F9DAJ an order under another contract?
Yes. SPE2DR26F9DAJ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DAJ competed?
The extent of competition for SPE2DR26F9DAJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award